Antibody-based protein depletion column

Monday, 06 April, 2009 | Supplied by: Merck


The Seppro IgY depletion platform is an antibody-based technology for processing plasma, serum and plant samples. It enables researchers to detect and analyse commonly obscured biomarkers in samples by removing highly abundant proteins.

The products are built using chicken-derived IgY antibodies, providing selectivity and low cross-reactivity. The Seppro platform removes 14 of the most abundant proteins from human serum or plasma, as well as other high and medium abundant proteins.

Additional products are available for the depletion of mouse and rat samples, as well as the removal of Rubisco.

The platform is complemented by a library of 700 polyclonal IgY antibodies, derived from chicken embryos and prepared using recombinant antigens.

Online: www.sigmaaldrich.com
Phone: 02 9841 0555
Related Products

Amsbio Acepix FFPE tissue blocks

Amsbio has expanded its range of high-quality formalin-fixed, paraffin-embedded (FFPE) tissues...

Promega Paradyme 27GY STR System

The Paradyme 27GY STR System features a novel enzyme that reduces the most common type of...

Mercodia Insulin MBeads Assay

The assay is designed to offer high accuracy by specifically measuring human insulin while...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd